cell lines bxpc 3 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
99
Structured Review
ATCC
cell lines bxpc 3
Cell Lines Bxpc 3, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 4829 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bxpc+3/BxPC-3/us12653850-1944-0-12
Average 99 stars, based on 4829 article reviews
Cell Lines Bxpc 3, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 4829 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bxpc+3/BxPC-3/us12653850-1944-0-12
Average 99 stars, based on 4829 article reviews
cell lines bxpc 3 - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
other:Article Title: Sulforaphane Enhances Cytotoxic Effects of Non-Thermal Plasma and Tirapazamine Combination Therapy in Pancreatic Adenocarcinoma Cells Article Snippet: Institutional Review Board Statement: The BxPC-3 and Mutagenesis:Article Title: Discovery of an Indole-Based p53-Y220C Reactivator with In Vivo Antitumor Activity via Structure-Guided Design. Article Snippet: The oncogenic Y220C mutation destabilizes the p53 DNAbinding domain by creating a druggable surface crevice.. Although the clinical advancement of PC14586 validates this target, the scarcity of structurally distinct correctors limits exploration of this chemical space.. Using a structureguided design strategy, we identified D2 as an indole-based p53-Y220C stabilizer that engages the mutation-induced cavity. Cell Culture:Article Title: Discovery of an Indole-Based p53-Y220C Reactivator with In Vivo Antitumor Activity via Structure-Guided Design. Article Snippet: The oncogenic Y220C mutation destabilizes the p53 DNAbinding domain by creating a druggable surface crevice.. Although the clinical advancement of PC14586 validates this target, the scarcity of structurally distinct correctors limits exploration of this chemical space.. Using a structureguided design strategy, we identified D2 as an indole-based p53-Y220C stabilizer that engages the mutation-induced cavity. Article Title: Lysosomal lipid metabolism promotes tumor cell invasion through local energetics and membrane lipid remodeling Article Snippet: .. |